Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38-e39

  • Benhamou, Pierre Yves
  • Madrolle, Stéphanie
  • Lablanche, Sandrine
  • Gallegos, Alexandre
  • Tourki, Yousra
  • Franc, Sylvia
  • Doron, Maeva
  • Charpentier, Guillaume

  • 1Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, Grenoble, France

    2Diabeloop SA, Grenoble, France

    3CERITD (Center for Study and Research for Improvement of the Treatment of Diabetes), Bioparc-Genopole Evry-Corbeil, Evry, France

    4Leti, CEA, Grenoble Alpes University, Grenoble, France

Corresponding author: Pierre Yves Benhamou,[email protected]

Clinical trial reg. no. NCT02987556,clinicaltrials.gov

Diabetes Care 43(10):p e167, October 2020. | DOI: 10.2337/dc20-1291
Copyright © 2020 by the American Diabetes Association, Inc.